Skip to content

Individualized prehabilitation between neoadjuvant treatment and surgery in high-risk patients with gastrointestinal tumor - a pilot study

Individualized prehabilitation between neoadjuvant treatment and surgery in high-risk patients with gastrointestinal tumor - a pilot study

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00018816
Enrollment
20
Registered
2019-10-01
Start date
2019-06-01
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C15 C16 C20

Interventions

Group 1: patients with oesophageal, gastral or rectal cancer who get neoadjuvant treatment in a curative intention and a surgery afterwards, an age of 70 years or more and an ASA-score of 3 or more T

Sponsors

Klinikum St. Georg GmbH
Lead Sponsor

Eligibility

Sex/Gender
All
Age
70 Years to 100 Years

Inclusion criteria

Inclusion criteria: min. 70 years old patients with oesophageal-, gastral or rectal cancer min. ASA-score of 3

Exclusion criteria

Exclusion criteria: dementia bed confinement emergency surgery indicated enteral nutrition not possible

Design outcomes

Primary

MeasureTime frame
complication rate in Clavien-Dindo

Secondary

MeasureTime frame
hospital length of stay, mortality, compliance

Countries

Germany

Contacts

Public ContactMaria Wobith

Klinikum St. Georg GmbH

maria.wobith@sanktgeorg.de00491742102374

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026